The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Cell culture technology has transformed the understanding of cellular behavior, disease mechanisms and therapeutic methods. Cell culture technology has made significant progress in science and medicine from its beginning in the late nineteenth century to the present. It has advanced from serum-free medium to organ-on-chip development, broadening its applicability in many domains, including regenerative medicine, disease modeling, drug discovery and cancer research. Thus, cell culture plays a crucial role in the biopharmaceutical sector, which is dedicated to creating novel treatments.
The biopharmaceutical industry has been witnessing tremendous growth recently due to the increasing demand for innovative therapies such as monoclonal antibodies, cell and gene therapies, vaccines and others. The demand for these therapies is due to various factors, such as the increasing prevalence of chronic diseases, rising healthcare expenditures, increasing awareness and novel product launches. The growing demand for cell cultures from the biopharmaceutical industry, coupled with rising R&D activities in stem cells and regenerative medicines, augments global market growth for cell culture media, sera and reagents.
The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.
The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.
Cell culture technology has transformed the understanding of cellular behavior, disease mechanisms and therapeutic methods. Cell culture technology has made significant progress in science and medicine from its beginning in the late nineteenth century to the present. It has advanced from serum-free medium to organ-on-chip development, broadening its applicability in many domains, including regenerative medicine, disease modeling, drug discovery and cancer research. Thus, cell culture plays a crucial role in the biopharmaceutical sector, which is dedicated to creating novel treatments.
The biopharmaceutical industry has been witnessing tremendous growth recently due to the increasing demand for innovative therapies such as monoclonal antibodies, cell and gene therapies, vaccines and others. The demand for these therapies is due to various factors, such as the increasing prevalence of chronic diseases, rising healthcare expenditures, increasing awareness and novel product launches. The growing demand for cell cultures from the biopharmaceutical industry, coupled with rising R&D activities in stem cells and regenerative medicines, augments global market growth for cell culture media, sera and reagents.
Report Scope
This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition.The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.
The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.
Report Includes
- 87 data tables and 55 additional tables
- An analysis of the global market for media, sera and reagents in the biotech industry
- Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region
- Discussion of the market potential, and forecasts for the market’s segments and sub-segments
- In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents
- Review of the current market status, key technology issues, industry value chain, Porter’s Five Forces, competitive landscape and R&D activity
- A discussion of the industry’s ESG challenges and practices
- Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
- Profiles of the leading companies
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Emerging Technologies
Chapter 5 Regulatory Scenario
Chapter 6 Market Segmentation Analysis
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in the Media, Sera and Reagents in Biotechnology Market: An ESG Perspective
Chapter 9 Appendix
List of Tables
List of Figures
Samples
LOADING...
Executive Summary
Reasons for Doing This Study:
Cell culture is the in vitro cultivation of cells in a controlled environment. Cell culture is gaining importance in biopharmaceutical industries with the growing demand for cell culture techniques in drug discovery and the production of biotherapeutics. Cell culture is used in academic research institutes to understand the physiology and biochemistry of cells.
Media, sera and reagents play an important role in the success of cell culture technology. The growing demand for novel therapeutics for the treatment of chronic disease and extensive research activities in regenerative medicine are anticipated to create high growth for media, sera and reagents during the forecast period.
The intent of this study is to provide readers with detailed information regarding cell culture, along with factors influencing market and key developments, with the goal of enabling decision-making regarding expansion and penetration in this market.
This report seeks to address the critically important topics of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets and specific disease segments and geographies.
Companies Mentioned
- ATCC
- BD
- BIO-TECHNE
- BIOWEST
- CORNING INC.
- DANAHER CORP.
- FUJIFILM IRVINE SCIENTIFIC
- LONZA
- MERCK KGAA
- MILTENYI BIOTEC
- PROMOCELL GMBH
- REPROCELL INC.
- SARTORIUS AG
- STEMCELL TECHNOLOGIES
- THERMO FISHER SCIENTIFIC INC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | March 2025 |
| Forecast Period | 2024 - 2029 |
| Estimated Market Value ( USD | $ 6.3 Billion |
| Forecasted Market Value ( USD | $ 9.3 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
